Meningococcal Acwy Disease

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2020-10-12
Clinical Trial Update: A Study To Evaluate A Booster Dose Of Menacwy-tt Vaccine Administered 10 Years After Healthy Subjects Aged 11-17 Years Received Either Menacwy-tt Vaccine (Nimenrix(Registered)) Or Mencevax Acwy(Registered). [Phase 3]
Phase 3 trial evaluating a booster dose of MenACWY-TT (Nimenrix) given 10 years after initial vaccination in healthy 11-17-year-olds; study …